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T/o s hALERT
Preventing Asthma and Death from 
MDI* Exposure During Spray-on Truck Bed Liner 
and Related Applications
WARNING!
Workers exposed to  MDI may develop serious or fa ta l resp ira tory disease.
Workers should take the fo llow ing steps  to  p ro tect themselves from  MDI* expo­
sure during spray-on app lica tions:
1. Be informed.
■ Participate in medical exams, medical monitor­
ing, air monitoring, respiratory fit-testing, and 
training programs offered by your employer.
■  Know the safety and health information and fol­
low all safety precautions provided by the manu­
facturers about the product(s) you are spraying.
2. Use resp ira to rs and PPE safely.
■ Make sure that you have been fit-tested for your 
respirators and that you have been trained in 
their proper use, storage, and maintenance.
■ Regularly inspect and maintain all component 
parts of supplied-air respirators and air-purifying 
respirators to assure their continued effective­
ness. The components include air compressors, 
hoses, regulators, facepiece, etc.
*M DI is m e thy len eb is (ph eny l isocyana te ). In th is  fa c t 
shee t, M DI re fers to  all M D I-based  isocyanates.
■ When spraying MDI,
— always use a full-facepiece, supplied-air res­
pirator operated in a pressure-demand or 
other positive-pressure mode and
— wear appropriate personal protective equip­
ment (PPE) (such as hooded coveralls, 
chemical-resistant gloves, and footwear).
■  Never remove or lift the respirator away from the 
face while in the spray enclosure. Use clear plas­
tic tear-away sheets on the visor to provide better 
visibility throughout the spray process.
■ Be aware that the highest MDI concentrations 
occur inside the spray enclosure.
■  After spraying, leave the spray enclosure before re­
moving your respirator and PPE and keep the ven­
tilation system running to exhaust any remaining 
MDI.
■  Do not re-enter the spray enclosure after spraying 
has stopped without PPE and a respirator (mini­
mum protection is an air-purifying respirator with 
a full facepiece equipped with a combination or­
ganic vapor/N95 filter cartridge).
■  Know the change-out schedule for the air- 
purifying respirator cartridge and strictly follow 
the schedule to make sure that you are ade­
quately protected from exposure to MDI.
3. Check the  ven tila tion  system  in the  
spray enclosure.
■ Make sure that the spray enclosure ventilation is 
operating correctly before beginning the spray pro­
cess.
■  Ensure that ventilation system intake filters are not 
clogged and are correctly installed in their frames.
■  Keep the ventilation system running until the MDI 
aerosol has been cleared from the spray enclo­
sure.
4. Use good work p ractices and personal 
hygiene.
■ Never eat or drink in work areas.
■ Wash hands and face before eating, drinking, or 
smoking.
5. Report symptoms.
■ Do the following if you have symptoms:
— Tell your employer if you develop breathing 
problems that could be related to MDI expo­
sure (wheezing, chest tightness, shortness 
of breath, or coughing).
— Seek medical evaluation of those symptoms.
— Do not spray or remain exposed to MDI un­
til you are medically evaluated for breathing 
problems that might be related to the spray­
ing process.
■ If you have been diagnosed with occupational 
asthma due to sensitization from MDI, do not 
work where you might be exposed to MDI.
Spraying base coat with protective equipment.
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Preventing Asthma and Death from 
MDI* Exposure During Spray-on Truck Bed Liner 
and Related Applications
WARNING!
Workers exposed to  MDI may develop serious or fa ta l resp ira to ry disease.
Employers should take the  fo llow ing  steps to  p ro tec t workers from  MDI expo­
sure during spray-on applications:
1. Provide workers who may be exposed 
to  MDI w ith in form ation and tra in ing  
about MDI as required by the  OSHA haz­
ard communication standard [29 CFRf 
1910.1200].
■ Inform workers about the serious health effects 
that may result from exposure to MDI and pro­
vide them with safety and health information.
■ Inform workers about any materials that may 
contain or be contaminated with MDI.
2. Provide respiratory protection and per­
sonal protective equipment to  workers 
who may be exposed to  MDI.
■ Develop, implement, and enforce a worksite- 
specific respiratory protection program that pro­
vides for medical monitoring, medical examina­
tions, respirator fit-testing, and respirator training.
*MDI is m e thy len eb is (ph eny l isocyona te ). In th is  fa c t 
she e t, MDI re fers to  all M D I-based  isocyanates. 
!Code o f  Federal R egu la tions.
■ Provide appropriate PPE (hooded coveralls, 
chemical-resistant gloves, and footwear) to work­
ers who use spray guns and to other workers who 
may be exposed to MDI.
■  Train workers to properly use, store, and main­
tain their respirators.
■  Regularly inspect and maintain all component 
parts of supplied-air and air-purifying respirators 
to assure their continued effectiveness. The com­
ponents include air compressors, hoses, regula­
tors, facepieces, etc.
■  Make sure respirators are professionally fitted.
■  When workers must wear prescription eye glass­
es under a full-facepiece respirator, provide them 
with prescription inserts designed to be compat­
ible with the respirator.
Supplied-air respirators
■ When workers are spraying MDI or are inside the 
spray enclosure during spraying, make sure they use 
full-facepiece, supplied-air respirators operated in a 
pressure-demand or other positive-pressure mode.
■  Make sure that supply air for the supplied-air 
respirator is taken from a clean, uncontaminated 
area that is well removed from any aerosolized 
MDI or other contaminants.
■ When workers must enter or re-enter the spray 
enclosure after spraying, make sure they use full- 
facepiece, air-purifying respirators equipped with a 
combination organic vapor/N95 filter cartridge. This 
is minimum acceptable protection for these condi­
tions.
■  Establish and implement a change-out schedule 
for air-purifying respirator cartridges.
3. Provide engineering contro ls.
■ Build a spray enclosure equipped with an exhaust 
ventilation system to
— isolate the spray process from the rest of the 
facility and
— maintain the enclosure under negative pres­
sure to control and contain MDI aerosols in 
the spray enclosure.
■  Determine the number of air changes per hour 
provided by the ventilation system and use this 
information to calculate the time required (after 
spraying) to reduce airborne MDI concentrations 
below the NIOSH recommended exposure limit 
(REL).
■  Make sure that workers are trained to use engi­
neering controls (such as spray enclosures with 
effective ventilation) and work practices to mini­
mize MDI exposures.
■ Allow only trained workers wearing NIOSH approved, 
full-facepiece, supplied-air respirators to enter 
the spray enclosure during spraying.
■ Establish and implement a preventive mainte­
nance program for the ventilation system.
4. Provide medical exam inations and 
surve illance fo r workers po ten tia lly  ex­
posed to  MDI.
■ Provide a preplacement medical examination 
and periodic medical monitoring for all potentially
Air-purifying respirators exposed workers to detect and prevent the acute 
and chronic effects of MDI exposure.
■ Remove from the workplace any worker showing 
signs or symptoms of MDI exposure.
■ Make sure the worker is medically evaluated be­
fore he or she is allowed to return to work.
■  If the medical evaluation determines that the 
worker is sensitized, the worker must not be al­
lowed to return to a job where MDI is used.
Truck in bed liner spray enclosure.
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ALERT
Preventing Asthma and Death from 
MDI* Exposure During Spray-on 
Truck Bed Liner and Related Applications
WARNING!
Workers exposed to  MDI* may develop serious or fa ta l resp ira to ry disease.
The National Ins titu te  fo r Occupational 
Safety and Health (NIOSH) requests as­
s is tance in preventing asthma, o ther 
resp ira to ry diseases, and death from  
exposure to  methylenebis(phenyl iso­
cyanate) (MDI). More than 10,000 U.S. 
workers are po ten tia lly  exposed to  MDI 
during spray-on tru ck  bed lin ing opera­
tions. This A le rt summarizes fou r case 
reports: one death and several incidents  
o f asthma or o ther resp ira to ry disease  
fo llow ing exposure to  MDI during spray- 
on tru ck  bed lin ing operations. In forma­
tion  about preventing adverse health e f­
fe c ts  from  exposure to  MDI is urgently  
needed by workers, employers, small 
business owners, and physicians and 
other health care providers.
NIOSH requests that editors of trade jour­
nals, safety and health officials, labor union 
leaders, educators, and MDI suppliers and 
manufacturers bring the recommendations 
in this Alert to the attention of all employers 
and workers at risk of MDI exposure through
*MDI is m ethy leneb is(pheny l isocyanate). In th is  a lert, 
MDI refers to  all M D I-based isocyanates.
spray-on and related applications. Your as­
sistance will help prevent asthma, other re­
spiratory disease, and death.
BACKGROUND
Spray-on polyurethane/polyurea products 
containing isocyanates such as MDI have 
been developed for a wide range of retail, 
commercial, and industrial uses to protect 
cement, wood, fiberglass, steel, and alumi­
num surfaces such as truck beds, trailers, 
boats, foundations, and decks. MDI, toluene 
diisocyanate (TDI), and the polyisocyanate 
products based on the diisocyanate hexa- 
methylene diisocyanate (HDI) are the most 
commonly used diisocyanates in the poly­
urethane industry. Isocyanates are widely 
used in the manufacture of flexible and rigid 
foams, fibers, coatings such as paints and 
varnishes, and elastomers. Isocyanates are 
increasingly used in the automobile industry, 
autobody repair, and building insulation ma­
terials. (See Appendix A for definitions and 
synonyms of MDI and information about its 
chemical structure.)
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Production and consumption data for the 
polyurethane industry in the United States 
and North America are available through 
the Alliance for the Polyurethanes Industry 
(API). Their publications End-Use Market 
Survey on the Polyurethane Industry [API 
2003] and Socio-Economic Impact o f Poly­
urethanes in the United States [API 2004a] 
provide the following facts:
■ In 2002, the U.S. market for polyure­
thane was 5,528 million pounds (87% 
of the North American market).
■ The manufacture of products such as flex­
ible slabstock, flexible molded foams, rig­
id foams, coatings, binders, elastomers, 
adhesives, sealants, reaction injection 
molding, thermoplastic polyurethanes, 
and spandex used 212 million pounds 
of MDI as a raw material and 1.3 billion 
pounds of polymeric MDI in 2002.
■ About 253,700 workers at 853 locations 
throughout the United States are em­
ployed in transportation industries that 
use polyurethane. Uses include resistant 
polyurethane coatings such as truck bed 
liners and other products such as head­
rests, armrests, adhesives, insulation, 
and other molded components used in 
vehicle production.
Information gathered by a major spray-on 
truck bed liner company identified 17 com­
panies that supply, distribute, and franchise 
spray-on truck bed lining equipment, mate­
rials, and products [Naik 2004]. Nationally, 
the number of spray-on truck bed liner busi­
nesses is estimated to exceed 2,000 [Lof- 
gren et al. 2003]. Press releases from two of 
the major truck bed liner companies indicate 
that the spray-on bed liner industry is rapidly 
growing. Conservative estimates indicate that 
more than 10,000 workers are employed in 
the spray-on bed lining industry nationwide.
Inspections by the Washington Industrial 
Safety and Health Administration (WISHA) 
of the Washington State Department of La­
bor and Industries at 13 spray-on truck bed 
lining businesses and a review of industrial 
insurance records found that workers are at 
risk of developing illnesses associated with 
diisocyanate exposure [Lofgren et al. 2003]. 
Seven of the 13 inspected worksites had 
MDI monomer air concentrations that were 
greater than the regulatory limit, resulting in 
regulatory citations.
During their preparation of the report on in­
spections in Washington State, the authors 
contacted NIOSH and requested help with 
developing engineering controls and alerting 
affected employers and workers through­
out the Nation. As a result, NIOSH began a 
study of the spray-on truck bed lining indus­
try. NIOSH conducted walk-through surveys 
at spray-on truck bed liner facilities in Wash­
ington State, Colorado, Ohio, and Kentucky 
[NIOSH 2003a; Almaguer et al. 2004]. Six 
sampling surveys were conducted in Ohio 
and Kentucky. The results of the NIOSH 
sampling surveys are described later in this 
document.
In 2003, Washington and Michigan actively 
began alerting the industry in their States of 
the hazards associated with spraying MDI in 
truck bed liner applications. In March 2003, 
WISHA issued a Hazard Alert warning of iso­
cyanate exposures related to the spray-on 
truck bed lining industry [WISHA 2003]. The 
Michigan Occupational Safety and Health 
Act News described a fatality that occurred 
in Michigan during the application of an MDI- 
based spray-on bed liner to the interior of a 
van in February 2003 [MIOSHA 2003]. In 
December 2003, the Michigan Fatality and 
Control Evaluation (MIFACE) Program issued 
a report on the death, and the Michigan Oc­
cupational Safety and Health Administration
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(MIOSHA) issued an Alert in January 2004 
[MIFACE 2003, MIOSHA 2004]. In February 
2004, WISHA issued a Hazard Alert Update 
briefly discussing the Michigan death and 
the health hazards associated with expo­
sure to isocyanates [WISHA 2004].
This Alert is intended to notify workers and 
employers in the truck bed lining and relat­
ed industries of the adverse health effects 
associated with exposure to MDI during the 
application of spray-on truck bed liners. 
The current Alert also provides preliminary 
recommendations to reduce worker expo­
sures to MDI during the spray-on bed liner 
process.
SPRAY-ON TRUCK BED LINING 
PROCESS
The spray-on truck bed lining process in­
volves applying a protective polyurethane or 
polyurea coating to the bed of pickup trucks 
or other vehicles and surfaces in a manner 
similar to undercoating. Bed liners are ap­
plied as a two-part resin. Part A is an MDI- 
based product; part B is usually a polyol or 
polyamine that reacts with the isocyanate to 
form a tough, resilient elastomeric surface 
coating. The MDI-based liners are applied 
to pickup truck beds and other surfaces to 
protect them from damage and to provide 
a nonskid surface. The spray-on application 
process is usually done in a spray enclo­
sure. The spray-on truck bed lining process 
is commonly performed in spray-on truck 
bed specialty shops, auto body centers, and 
auto dealerships (see Figure 1).
NIOSH identified two spray-on processes 
commonly found in the industry [Heitbrink 
and Almaguer 2003]: one process applies 
truck bed liners at room temperature and
Figure 1. Spraying base coat w ith protective equipment.
pressures of approximately 50 pounds per 
square inch (low temperature/low pressure); 
a second process applies truck bed liners at 
temperatures above 165 °F and pressures 
of approximately 1,500 pounds per square 
inch (high temperature/high pressure). In 
both processes, the A and B components 
are pumped separately to the spray gun 
and mixed at the time of application. The 
worker uses a hand-held spray gun to ap­
ply the rapidly curing product onto the truck 
bed interior. The shape of the spray pattern 
is determined by the nozzle shape. To cre­
ate a textured, nonslip surface on the bed, a 
small quantity of the coating is sprayed into 
the air, allowing the product to settle onto 
the truck bed. To obtain a bed liner thick­
ness of 0.125-0.25 inches (a standard in 
the industry), approximately 50 pounds of 
the two-part resin (part A and part B) are 
sprayed onto the bed and inside walls of a 
typical pickup truck (see Figure 2).
A third type of spray-on process that was 
not included in the NIOSH sampling sur­
veys is the cold-batch, pre-mix process. The 
information contained in this Alert may apply 
to this process as well. During this process, 
isocyanate/resin and catalyst materials are
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Figure 2. Spraying texturizing coat with protective equipment.
generally mixed in small quantities (quarts 
or gallons) at room temperature with a 
high-speed drill. Afterwards, the mixture is 
poured into a hopper gun and applied at 
30-60 pounds per square inch from inside 
the truck bed. The chemicals used in the 
cold-batch operations typically contain less 
MDI (less than 20%). However, the cold- 
batch materials contain higher amounts of 
flammable solvents (toluene and N-butyl 
acetate) which should have their own expo­
sure prevention and ventilation requirements. 
Cold-batch systems are popular because of 
the lower startup costs [Krupinski 2005].
SPRAY APPLICATIONS OTHER 
THAN TRUCK BED LINING
Polyurethane and polyurea coatings are 
marketed and used for truck trailers, house 
decks, walls, foundations and sports floor­
ing, and they are likely to be used for other 
applications as well. In many cases, these 
applications use the same or similar chemi­
cals, spray techniques, and equipment as
the spray-on truck bed lining process. Be­
cause of these similarities, excessive expo­
sure to MDI may occur during these related 
applications, resulting in risk to spray gun 
users and other nearby workers. Owners 
and managers of these operations should 
assess and sample as necessary as well 
as implement needed controls and work 
practices, including engineering controls, 
worksite-specific respiratory protection pro­
grams, chemical hazard training, administra­
tive controls, and use of personal protective 
equipment for exposed workers as outlined 
in this Alert [Lofgren et al. 2003].
HEALTH EFFECTS OF 
ISOCYANATES
Isocyanates are the leading attributable 
chemical cause of occupational asthma in 
the United States and many other industri­
alized countries [Tarlo et al. 1997b]. Work­
ers with asthma symptoms from isocyanate 
exposure often continue to have symptoms 
after exposures have been terminated. Af­
fected workers often have to leave their jobs 
to prevent progression of respiratory symp­
toms. The major route of work-related ex­
posure to MDI is inhalation of the vapor or 
aerosol.
Because the odor threshold for MDI is many 
times above the recommended exposure 
limit (REL), smell should never be relied on 
as an indication of exposure, nor should the 
absence of odor be used to indicate safety. 
MDI can be detected by odor only after dan­
gerous concentrations exist, resulting in po­
tential overexposure.
Exposure may also occur through skin con­
tact during the handling of liquid MDI-based 
products. Work-related exposure normally
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occurs during the spray application of MDI- 
based products. In 1996, NIOSH issued 
Preventing Asthma and Death from Isocya­
nate Exposure, which summarizes reported 
cases of disease and death following occu­
pational exposure to diisocyanates and di­
isocyanate-based products [NIOSH 1996].
Irritation and Lung Injury
MDI and other isocyanates may irritate the 
mucous membranes of the eyes, upper and 
lower respiratory tracts, gastrointestinal tract, 
and skin [Swensson et al. 1955; Fisher 
1967; Upjohn Company 1970; Lofgren et 
al. 2003]. Eye tearing, nose and throat ir­
ritation, and cough may occur [Littorin et al. 
2000]. Respiratory irritation may progress to 
chronic upper and lower respiratory symp­
toms, although symptoms of local irritation 
do not reliably indicate chronic respiratory 
conditions [Wang and Petsonk 2004]. Acute 
respiratory distress syndrome or reactive air­
ways dysfunction syndrome may also result 
from short-term high exposures [Tarlo et al. 
1997b; Banks 1998].
Respiratory Sensitization
Isocyanates can sensitize workers, making 
them subject to severe asthma attacks if 
they are exposed again, even when concen­
trations are continuously below the NIOSH 
REL [NIOSH 1973, 1978; Banks 1998]. 
Skin exposures may be associated with the 
onset of respiratory symptoms [Petsonk et 
al. 2000]. Respiratory disorders associated 
with isocyanate exposure include asthma 
and hypersensitivity pneumonitis [Baur et 
al. 1984; Baur 1995]. Sensitization may 
result from a single episode of overexposure 
or intermittent exposures at low concentra­
tions. Once a worker is sensitized, even low 
concentrations may trigger symptoms such
as wheezing, chest tightness, shortness of 
breath, and cough. Persons with chronic 
hypersensitivity pneumonitis may also ex­
perience fatigue and weight loss. These 
symptoms may begin immediately or may 
be delayed for up to 8 hours after exposure. 
Death from severe asthma in sensitized sub­
jects has been reported [Fabbri et al. 1988; 
MIFACE 2003].
Carcinogenicity
Isocyanates may cause cancer in animals; 
however, evidence is insufficient to describe 
the carcinogenic potential of MDI in hu­
mans. Data from recent studies show that 
methylene dianiline (MDA), a known animal 
carcinogen and the principal metabolite of 
MDI monomer, is found in the blood of MDI- 
exposed rats and in the urine of humans 
exposed to a mixture of polymeric MDI and 
MDI monomer [NIOSH 1986; Sepai et al. 
1995]. Another study found that a commer­
cial grade of MDI (45% MDI monomer by 
weight) induced chromosome aberrations 
in human blood lymphocyte cultures after 
a 24-hour treatment [Maki-Paakkenen and 
Norppa 1987]. NIOSH recommends that 
work-related exposure to MDI be minimized 
because of the potential for respiratory sen­
sitization and the potential carcinogenicity 
of the metabolite MDA [NIOSH 1986].
CURRENT EXPOSURE LIMITS
Occupational exposure standards for MDI 
are based on respiratory irritation and sen­
sitization. The available human evidence 
is insufficient to describe the carcinogenic 
potential of MDI [NIOSH 1989]. The evolu­
tion of the occupational exposure standards 
for isocyanates is discussed in the litera­
ture review Polyisocyanates in Occupational
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Environments: A Critical Review o f Expo­
sure Limits and Metrics [Bello et al. 2004]. 
The isocyanate product frequently used in 
bed-liner formulations consists of varying 
amounts of MDI monomer and higher mo­
lecular weight species. Long-term aerosol 
inhalation studies suggest that monomeric 
MDI and polymeric MDI, which typically con­
tain 50% monomer, have a similar response 
in rat lungs [Feron et al. 2001]. Mandatory 
and recommended limits have been estab­
lished for MDI monomer, as discussed be­
low. However, no recommended or regu­
latory limit exists for higher molecular weight 
species at this time. Therefore, regardless of 
the relative amount of MDI monomer pres­
ent, owners and workers are encouraged to 
adhere to the control methods outlined in 
this Alert whenever MDI aerosols may be 
generated through a spray-on bed-lining op­
eration.
NIOSH
NIOSH recommends that MDI monomer ex­
posure be limited to 0.05 milligram per cu­
bic meter of air (mg/m3) or 0.005 part per 
million parts of air (0.005 ppm) as a time- 
weighted average (TWA) for up to a 10-hour 
workday during a 40-hour workweek, with 
a ceiling limit of 0.2 mg/m3 (0.02 ppm) 
for any 10-minute period [NIOSH 1978]. 
This NIOSH REL is intended to prevent acute 
and chronic irritation and sensitization of 
workers but not to prevent health effects in 
workers who are already sensitized. Avail­
able data do not indicate a concentration 
at which MDI fails to produce adverse re­
actions in sensitized persons. Unless oth­
erwise stated, use of the term NIOSH REL 
in this document means the NIOSH REL of
0.2 mg/m3 as a 10-minute ceiling concen­
tration when referring to spray-on truck bed 
liner processes.
OSHA
The current Occupational Safety and Health 
Administration (OSHA) permissible exposure 
limit (PEL) for MDI monomer is 0.2 mg/m3 as a 





In response to health concerns, Washington 
Industrial Safety and Health Administration 
(WISHA) inspectors conducted exposure as­
sessments at 13 spray-on bedliner estab­
lishments [Lofgren et al. 2003]. Airborne 
concentrations of MDI monomer during the 
10- to 20-minute application process varied 
between shops and ranged from 0.045 to 
6.5 mg/m3. In 7 of the 13 shops, airborne 
concentrations of MDI monomer exceeded 
the State and OSHA ceiling limit of 0.2 mg/m3. 
The method used for most samples consist­
ed of an open-faced cassette having a filter 
treated with 1-(2-pyridyl) piperazine. WISHA 
concluded that conditions contributing to 
excess exposure included inadequate ex­
haust and make-up air, clogged ventilation 
filters, and a lack of training and awareness 
of the hazard. Workers who applied spray 
used either a supplied-air respirator or an 
air-purifying respirator with filter cartridge. 
Companies were cited for deficient respi­
rators, inadequate respirator training pro­
grams, and lack of respirator fit-testing and 
engineering controls. Seven of the worksites 
with overexposure to MDI had one or more 
serious violations related to respirator use.
*Code o f  F edera l R egu lations. See CFR in re ferences.
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In addition, one establishment using a bed- 
liner product containing a flammable sol­
vent received a violation for the presence of 
sources of ignition in the spray area.
NIOSH
The following summarizes MDI monomer 
exposure assessments from NIOSH surveys 
conducted at six spray-on truck bed liner 
sites. These exposure assessment sites in­
cluded three surveys at low-temperature/ 
low-pressure operations and three surveys 
at high-temperature/high-pressure opera­
tions. Samples were collected in the spray 
enclosures during the bedliner applica­
tion process, in truck preparation areas, in 
the office areas, and outdoors as close as 
practicable to the spray enclosure exhaust 
grill. Sampling was done for the duration of 
the process, which ranged from 16 to 43 
minutes in the spray enclosure. Longer- 
duration sampling was done in areas outside 
the spray enclosure. The air samples were 
collected and analyzed using NIOSH Method 
5525 [isocyanates, total (MAP)], which uses 
1-(9-anthracenylmethyl)-piperazine (MAP) as 
the derivatizing reagent [NIOSH 2003b]. In 
accordance with the recommendations in 
NIOSH Method 5525 for sampling MDI aero­
sols, an impinger with MAP reagent solution 
followed by a MAP reagent-coated filter was 
used for collecting the air sample. The labo­
ratory analysis of samples used high-perfor­
mance liquid chromotography with ultravio­
let absorbance/fluorescence detection.
Spray Enclosure
The data from these six surveys show that the 
greatest risk for exposure occurs, as expect­
ed, in the spray enclosure. Airborne concen­
trations of MDI monomer were up to 27 times 
the NIOSH REL of 0.2 mg/m3 as a 10-minute
ceiling concentration in the spray enclosure 
during the spray-on process. The geometric 
mean MDI monomer concentration in the 
spray enclosures at the low-temperature/ 
low-pressure process was 0.99 mg/m3, or 
approximately 5 times the NIOSH REL. The 
geometric mean MDI monomer concentra­
tion in the spray enclosures at the high- 
temperature/high-pressure process was
0.78 mg/m3 or approximately 4 times the 
NIOSH REL. Nonmonomeric MDI was de­
tected in the spray enclosure samples and 
ranged up to 42% of the total isocyanate 
group. All workers applying spray wore sup- 
plied-air, full-facepiece respirators, except 
for one who wore a supplied-air, half-face- 
piece respirator [Almaguer et al. 2004].
After the spray application process, post­
spray air samples were collected inside 
the spray enclosure. Eight of 12 post-spray 
samples showed low concentrations of MDI 
monomer; 4 of the 12 samples had non- 
detectable concentrations. These samples 
were typically 15- to 30-minute samples 
and ranged from below the limit of detection 
to 0.08 mg/m3. These results are averaged 
over the duration of the sample; concentra­
tions immediately after spray application 
are expected to be higher and may require 
respiratory protection when re-entering the 
booth (usually to remove the vehicle) (see 
Recommendations).
Truck P reparation Area
Airborne MDI monomer in the truck prepa­
ration area averaged 0.56% of that in the 
spray enclosure. Eight of the 12 samples 
taken in the truck preparation area were 
below the limit of detection. The four 
samples above the limit of detection had 
concentrations that ranged from 0.0057 
to 0.022 mg/m3. Unlike spray gun users, 
the workers in the truck preparation areas
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did not wear respirators designed to protect 
from exposure to MDI. The concentrations 
in the truck preparation area were below the 
NIOSH REL. However, detecting any MDI in 
the truck preparation area indicates that 
the spray enclosure was not under negative 
pressure as recommended. Because of the 
potential for worker sensitization to MDI, the 
spray enclosure should be maintained under 
a negative pressure to minimize the possibil­
ity that MDI monomer will escape from the 
spray enclosure to the truck preparation area 
or other adjacent work areas, and prevent 
worker sensitization.
Office Area
In five of the six surveys, airborne MDI mono­
mer in the office/lobby areas was below the 
limit of detection. Trace concentrations of 
MDI monomer (below the limit of quantita­
tion) were detected in the office/lobby area 
of one shop. Again, this finding indicates 
that the spray enclosure was not under neg­
ative pressure as recommended, thereby 
presenting the potential for exposure to the 
office occupants. Placing the office/lobby 
areas as far as possible from the spray en­
closure and exhaust areas minimizes pos­
sible exposure to MDI in these areas.
Exhaust Area
Five of eleven outdoor samples for MDI 
monomer taken near the spray enclosure 
exhaust had concentrations greater than 
the lim it of detection; the highest was
0.41 mg/m3. These data indicate a poten­
tial for exposure to MDI in the exhaust area 
of the building, requiring restrictions as ad­
dressed in the Recommendations.
Observations at the surveyed worksites sug­
gest effective exhaust ventilation may have 
reduced MDI monomer concentrations in the
spray enclosure during spray applications [Al- 
maguer et al. 2004]. Only one site had an 
exhaust system designed to effectively cap­
ture contaiminants in the spray enclosure; at 
this site, airborne MDI was reduced to con­
centrations near the NIOSH REL. Airborne 
concentrations at 5 other sites with general 
exhaust ventilation were 3 to 27 times the 
NIOSH REL.
CASE REPORTS
The following case reports highlight exam­
ples of isocyanate-induced asthma, other 
respiratory disease, and death.
Case 1—Spray-on Truck Bed 
Lining (Fatal Asthma)
A 45-year-old male worker with 1 year of 
tenure died from an acute asthma attack 
after spraying an MDI-based bed liner onto 
the floor and sides of a cargo van interior. 
The worker was wearing a half-mask, sup- 
plied-air respirator as well as latex gloves 
and coveralls. The spray area was defined 
only by “two curtains that could be pulled 
together to enclose the area and limit prod­
uct overspray into the general shop area.” 
The room had no local exhaust ventila­
tion. Room ventilation during the spray-on 
bedliner application was provided by rais­
ing the overhead door a few feet, opening 
the door near the rust-proofing area, and 
placing a box fan at this door to provide 
air circulation. After completing the job, the 
worker turned off the mixer for the spray-liner 
components (MDI and polyether polyol). He 
disconnected his airline from the respirator 
and walked around to the front of the build­
ing, where a coworker found him in acute 
respiratory distress. The coworker took him 
to a nearby urgent care facility where he de­
veloped cardiac arrest. He did not respond
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to cardiopulmonary resuscitation. An ambu­
lance took the worker to the local hospital 
emergency room where he was declared 
dead. After an autopsy, the county medical 
examiner stated that the worker had died of 
an “acute asthmatic reaction due to inhala­
tion of chemicals.”
In the past, the worker had tried to spray 
bed liners when customers and cowork­
ers were not present because of the strong 
odors associated with the product. After the 
fatality, coworkers informed the owner that 
the victim said he had difficulty breathing 
after applying the bed liners and that he had 
used an inhaler.
This fatality may have been caused by MDI 
sensitization. The spray area was enclosed 
with a curtain (not a permanent enclosure) 
and had no dedicated exhaust ventilation. 
The worker used a spray-gun and a half­
mask, supplied-air respirator. Furthermore, 
the MIFACE report indicates that the worker 
told coworkers that he had had previous 
breathing difficulties after spraying bed lin­
ers and that he had used an inhaler in the 
past. This suggests that MDI sensitization 
probably occurred in the past and played a 
significant part in the fatality. The informa­
tion reinforces the need for strict adherence 
to the recommendations in this Alert.
Whether the worker knew that his past 
breathing problems were associated with 
his exposures at work was unclear, since he 
did not report them to the owner. No expo­
sure assessment data are available for this 
fatality [MIFACE 2003; MIOSHA 2004].
Case 2—Spray-on Truck Bed 
Lining (Asthma)
A 29-year-old male ex-smoker who worked 
spraying truck bed liners arrived at a hospital
emergency room with complaints of chest 
discomfort and wheezing. He reported hav­
ing been exposed to “fumes” generated 
during the application of MDI-based spray- 
on truck bed liners. He reported increasingly 
frequent episodes of shortness of breath 
and wheezing associated with exposure to 
isocyanates during 8 months of work at the 
truck bed lining company. The worker was 
diagnosed with asthma, treated with in­
haled bronchodilators and intravenous ste- 
riods, and advised to see a pulmonologist. 
The emergency room record indicated that 
the physician failed to identify the isocya­
nate exposure reported by the worker as a 
possible etiology of the worker’s asthma 
[Bonauto and Lofgren 2004].
Case 3—Spray-on Truck Bed 
Lining (Asthma)
A 30-year-old man developed rhinitis, a 
cough, wheezing, and shortness of breath 
4 months after starting work spraying truck 
bed liners. On one occasion, the worker re­
ported to the emergency room but was not 
diagnosed with asthma. Symptoms persisted 
with daily episodes of shortness of breath, 
wheezing, and nausea. These symptoms oc­
curred at midday after four to five bed liner 
applications. After 4 months of symptoms, 
which culminated in hospitalization for re­
spiratory distress, the worker was diagnosed 
with work-related asthma from exposure to 
MDI. After hospitalization, the worker was 
documented to have nonspecific bronchial 
hyperreactivity by methacholine challenge 
testing. No inhalation challenge with MDI or 
workplace challenge testing was ever per­
formed. The worker was removed from the 
workplace.
One year later, the worker was employed 
elsewhere as a manual laborer. He still had
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symptomatic asthma and was maintained 
on bronchodilators and inhaled steroids 
[Bonauto and Lofgren 2004].
Case 4—Spray-on Truck Bed 
Lining (Asthma)
A 22-year-old worker who used a spray gun 
was employed in the truck bed lining indus­
try for 18 months. He developed a runny 
nose and nasal congestion that occurred 
during the workweek but improved over the 
weekend. Increased breathing difficulty on 
exertion restricted his daily activities. The 
worker underwent a medical evaluation that 
included spirometry before and after the 
administration of bronchodilators. He was 
documented to have a reversible airflow lim­
itation and was diagnosed with asthma. No 
workplace challenge testing was performed. 
The material safety data sheets (MSDSs) 
provided to the medical personnel revealed 
that the spray-on bed liner material consist­
ed of 50% to 60% MDI monomer and 5% 
to 20% diisooctyl phthalate. The worker was 
removed from the workplace.
A year and a half after medical removal from 
the workplace, the affected worker was still 
unemployed. He continued to have symp­
tomatic asthma and was maintained on 
bronchodilators and steroid inhalers [Bon­
auto and Lofgren 2004].
CONCLUSIONS
The cases described in this document reveal 
the potentially serious nature of respiratory 
disease resulting from exposures to MDI in 
the spray-on truck bed liner industry. Expo­
sures may increase the risk of serious respi­
ratory disease, respiratory sensitization, and 
death. MDI concentrations generated by the 
spray-on application of truck bed liners at
the NIOSH exposure assessment sites rou­
tinely exceeded the NIOSH and OSHA ceil­
ing limits and varied throughout the process 
with unpredictable, rapid increases in air­
borne concentrations. On the basis of these 
findings, NIOSH concludes that only a full- 
facepiece, supplied-air respirator provides 
the necessary protection during MDI spray 
operations.
RECOMMENDATIONS
Manufacturers and distributors of spray-on 
polyurethane/polyurea products contain­
ing MDI and other isocyanates should work 
together to assess and determine the best 
controls for the spray-on bed liner process. 
The ultimate goal is to establish procedures 
and develop controls (such as proper ven­
tilation) to minimize MDI concentrations 
within the spray enclosures. These proce­
dures and controls—together with respi­
rator use, a written respiratory protection 
program, and ongoing worker training—will 
reduce the risk for worker exposures during 
the spray-on process.
General Responsibilities for Shop 
Owners and Workers to Prevent 
MDI Exposures
■ Use any training, information, and litera­
ture available through the manufacturers, 
distributors, franchisers, and government 
agencies (see examples under manufac­
turer responsibilities).
■ Isolate the spray process by building an 
enclosure equipped with exhaust venti­
lation.
■ Use a pressure manometer or tracer 
smoke along cracks and walls to en­
sure that the spray enclosure is under
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negative pressure and prevents the es­
cape of MDI to adjacent work areas.
■ Use a full-facepiece, supplied-air respira­
tor and wear personal protective clothing 
such as hooded coveralls, chemical- 
resistant gloves, and footwear to prevent 
dermal absorption during the spray ap­
plication process.
■ When entering or re-entering the en­
closure immediately after spraying, use 
a full-facepiece, air-purifying respirator 
equipped with a combination N95 filter/ 
organic vapor cartridge as minimum pro­
tection and wear appropriate clothing to 
prevent dermal exposure.
■ To prevent fouling of the exhaust system 
and fan blades, filter all exhaust air at its 
collection point within the spray enclosure 
before it enters the exhaust system.
■ Discharge exhaust from the spray 
enclosure away from occupied areas 
and ensure that the exhaust outlet 
is located away from HVAC air sup­
ply intakes and supplied-air respirator 
pumps/compressors.
■ Ensure that only authorized persons 
trained in the use of safe work prac­
tices, ventilation, and personal protec­
tive equipment are allowed to perform 
spraying.
General Responsibilities of 
Manufacturers, Distributors, and 
Franchisers of Spray-on Chemicals 
and Equipment
■ Provide safety and health information to 
users of your chemicals and equipment. 
Include information about design of 
spray enclosures, engineering controls, 
safe work practices, and the hazards of
exposure. These two references are ex­
cellent examples of useful information:
— MDI and TDI: Safety, Health and the 
Environment [Allport et al. 2003], 
by the International Isocyanate Insti­
tute Inc. for occupational safety and 
health information about MDI.
— The API brochure Truck Bed Liners: 
Worker Protection, available in both 
English and Spanish. The brochure 
outlines safety precautions for spray 
gun users who apply spray-on truck 
bed liners [API 2004b]. The brochure 
is available through the API Web site 
at www.polyurethane.org.
■ Develop, publish, and distribute addi­
tional safety and health resources to help 
workers using spray-on MDI products.
Detailed Recommendations
The following sections provide detailed rec­
ommendations for this industry, including fur­
ther guidance about the choice of respirators 
and appropriate ventilation parameters.
Product Substitu tion
When feasible, substitute a less hazard­
ous material for MDI and other isocyanates. 
NIOSH policy is always to recommend using a 
less toxic substitute if available. Water-borne 
acrylic coatings, polysulfide rubber coating, 
and epoxy are other chemicals that have 
been used to make truck bed liners. Drop- 
in truck bed liners are also commercially 
available. NIOSH cannot address the quality 
or performance and has not addressed the 
safety of these products.
In addition, using substitute chemical pro­
cesses or products may have advantages and 
disadvantages, including safety and health 
issues that are not addressed in this Alert.
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Equipment/Formulation Modifica tion
■ Manufacturing and distribution: Investi­
gate design changes that result in less 
aerosolization or fewer fugitive emissions 
during the spray process.
■ Bed liner industry: Investigate potential 
process changes and work practices to 
determine whether reduced application 
pressure and slower application tech­
niques result in lower MDI monomer air 
concentrations during the spray process.
■ Chemical manufacturing: Consider chang­
es in chemistry and formulation that would 
reduce the amount of fugitive MDI released 
during spraying.
These design, process, and formulation chang­
es could reduce airborne MDI, resulting in 
reduced worker exposures. They would also 
place less financial burden on retail owners 
and operators in controlling airborne contam­
inants during the spray process. Furthermore, 
less overspray would produce less waste and 
provide further economic benefit for the retail 
owner. Unverified evidence from a spray-on 
bed liner company suggests that using lower 
pressures (10 pounds per square inch) may 
reduce airborne MDI concentrations and thus 
lower the exposure.
Spray Enclosure and Ventilation  
Ventilation design (see Appendix B)
■  Design and build a spray enclosure to 
isolate the spray process and contain 
airborne MDI within the enclosure.
■ Minimize the size of enclosure to the 
smallest floor area and room volume 
compatible with the operation. This helps 
to maximize the efficiency of the ventila­
tion system.
■ Equip the spray enclosure with an ex­
haust ventilation system to capture va­
por and particulate MDI near the point of 
generation.
■ Ensure that the spray enclosure is under 
negative pressure to prevent leakage of 
airborne MDI into other areas within the 
shop.
■ Provide clean “make-up” air to the spray 
enclosure to replenish exhausted con­
taminated air.
■ Place the make-up air supply and exhaust 
locations of this ventilation system so that 
the system generates a directed air (push­
pull type) flow that maximizes ventilation 
efficiency and contaminant control.
■ Discharge the exhaust high above the 
roof and away from air intakes, garage 
doors, or other openings where the ex­
haust could re-enter the shop. Also 
ensure that the exhaust is discharged 
above the roof recirculation region (See 
Industrial Ventilation: A Manual o f Rec­
ommended Practice [ACGIH 2004] to 
determine the recirculation region).
■ Control access to exhaust discharge areas 
by physical barriers and warning signs.
Work practices
Spray gun users should be trained to make
their work practices compatible with the
control concepts of the ventilation system:
■ Avoid standing between the spray noz­
zle and the ventilation system exhaust 
hood.
■ Work with the spray nozzle downstream of 
the breathing zone, where the MDI con­
taminant will be diluted, directed away
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from the breathing zone, and less likely 
to contribute to the worker’s exposure.
■ Allow the exhaust ventilation system to 
operate for an additional period at the 
end of spraying operations before deac­
tivating the exhaust or allowing person­
nel to enter the spray enclosure without 
proper respiratory protection (see Respi­
ratory Protection, page 14). This delay 
allows the ventilation system to purge 
or remove most remaining airborne con­
taminants.
■ Do not enter exhaust discharge areas 
without respiratory protection.
Ventilation system capabilities
■ Obtain a site-specific exposure assess­
ment that includes sampling data at 
desired intervals following the spray op­
eration. These data are the best way to 
determine the purge time (time required 
to reduce MDI concentrations consis­
tently below the NIOSH REL) required for 
your ventilation system.
■ In the absence of exposure assessment 
data, determine the time required for the 
ventilation system to exhaust an air vol­
ume equal to a single room air change.
■ Calculate the required purge time, al­
lowing sufficient time for at least three 
complete air exchanges— or even longer 
for systems with poor air mixing.
■ During the purge time, use respiratory pro­
tection when entering the spray enclosure 
(see Respiratory Protection, page 14).
■ For assistance calculating the time re­
quired for a single air change and the 
purge time of the ventilation system, see 
Appendix B.
Ventilation maintenance
■ At least once per month, inspect and 
maintain the ventilation equipment to 
ensure adequate system performance 
(or more frequently if a decrease in per­
formance is suspected).
■ Document and re-evaluate baseline ven­
tilation performance measurements, in­
cluding hood static pressure, pressure 
drop across filters, and velocity or volu­
metric flow measurements for indications 
of system performance degradation.
■ Develop a maintenance schedule to 
change exhaust filters as needed to pre­
vent reduced airflow.
■ Ensure that exhaust fans have inspec­
tion access doors.
■ Ensure proper filter placement at air ex­
haust points to prevent filter bypass and 
the fouling of the exhaust system.
■ Inspect fan blades regularly for material 
buildup and clean them to prevent a de­
crease in system performance.
■ Check fan belts for deterioration and 
slippage and replace as necessary.
■ Follow lock-out, tag-out procedures 
[29 CFR 1910.147] during inspection 
and maintenance procedures whenever 
worker injury may result from unexpected 
start-up of this equipment.
Spraying in Enclosed Areas
■ Take additional precautions when spray­
ing inside vans, enclosed trailers (e.g., 
horse trailers), and other similarly en­
closed spaces.
■ Determine whether the area to be sprayed 
meets the definition of a confined space 
and, if so, follow all OSHA requirements
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for working in a confined space [29 CFR 
1910.146].
■ Use supplemental local exhaust ventila­
tion in addition to the exhaust ventilation 
of the spray enclosure.
■ Wear a full-facepiece, supplied-air res­
pirator and appropriate clothing to mini­
mize the exposure.
Worker Isolation
■ Restrict access to the spray enclosure to 
spray gun users.
■ Allow only essential workers wearing ap­
propriate respiratory protection into the 
truck preparation areas or other areas 
where workers may be exposed to iso­
cyanates.
Exposure Monitoring
■ If you are a shop owner, conduct an ex­
posure assessment for airborne MDI at 
the onset of business and any time a 
major change (structural or ventilation) 
is made to the spray enclosure.
— Even if you install a ventilated en­
closure design tested as effective 
for a product and process, conduct 
exposure monitoring to verify the ef­
fectiveness and proper installation at 
that site.
— Ensure that spray gun users and the 
areas adjacent to the spray enclo­
sures are sampled.
— Use the appropriate sampling meth­
ods, as described in the NIOSH and 
OSHA analytical methods [NIOSH 
2003b, OSHA 1989].
■ Use the NIOSH REL of 0.2 mg/m3 as a 
10-minute or the OSHA PEL of 0.2 mg/m3
as a 15-minute ceiling limit concentra­
tion when interpreting exposure monitor­
ing results. The short-term, intermittent 
nature of the spray-on truck bed liner 
process makes the NIOSH or OSHA ceil­
ing limits the most appropriate exposure 
criteria for this process. Collect personal 
breathing zone samples from the time a 
spray operation begins to the time when 
spraying has stopped (typically a 10-20 
minute period). Compare results with the 
NIOSH or OSHA ceiling limit.
Additional assistance about managing this 
or other hazards can be obtained from the 
free, onsite OSHA consultation service in 
your State. For information about the OSHA 
Consultation Program, visit www.osha.gov/ 
dcsp/smallbusiness/consult.html or call 1 - 
800-321-OSHA (1-800-321-6742).
Respiratory P rotection
Typically, respirators should not be used as 
the primary control for routine operations 
except during situations such as implemen­
tation of engineering controls, some short- 
duration maintenance procedures, and emer­
gencies. NIOSH exposure assessment data 
show that the engineering controls at the 
NIOSH survey sites did not reduce MDI con­
centrations below the occupational criteria, 
even at the sites with the best ventilation 
controls [Almaguer et al. 2004]. Airborne 
MDI monomer concentrations in the spray 
enclosures during the spray-on application 
process routinely exceed both the NIOSH 
10-minute ceiling limit (0.2 mg/m3) and the 
OSHA PEL as a 15-minute ceiling concen­
tration (0.2 mg/m3). Therefore, NIOSH rec­
ommends the following respiratory protec­
tion for the spray-on truck bed liner industry. 
(See Appendix C for more information about 
respirators and respiratory protection.)
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Use supplied-air respirators when
spraying MDI
■ When spraying MDI-based products (in­
cluding spray-on truck bed liners), use 
only supplied-air, NIOSH-certified respi­
rators [42 CFR 84] with a full facepiece 
operated in a pressure-demand mode. 
MDI concentrations generated during 
the spraying process routinely exceed 
both the NIOSH and OSHA ceiling limits, 
even with engineering controls. NIOSH 
does not recommend air-purifying respi­
rators for the spray-on truck bed-liner 
industry during the spray application, 
even though OSHA allows the use of air- 
purifying respirators for isocyanates un­
der certain circumstances in accordance 
with the revised OSHA respiratory protec­
tion standard [29 CFR 1910.134(d)(1)(i) 
and 1910.134(d)(3)(iii)] (see the OSHA 
Standard Interpretations Letter dated 
07/18/2000 and titled Selection o f Air 
Purifying Respirators for Gases and Va­
pors with Poor Warning Properties (Diiso­
cyanates) [OSHA 2000]).
■ While in the spray enclosure, do not lift 
or remove the respirator facepiece for 
any reason.
■ If visibility is a problem during or after 
spraying, apply several tear-away layers 
of clear plastic film to the respirator visor 
before entering the booth. This would al­
low the worker to remove the top layer 
for increased visibility as needed during 
the spray-on process.
Use air-purifying respirators for entry
into the enclosure after spraying
■ To enter the spray enclosure after spray­
ing is completed, use a full-facepiece, 
air-purifying respirator with an appropri­
ate cartridge changeout schedule that
is strictly enforced. NIOSH data indicate 
that MDI aerosol is still present in the air 
after spraying. An air-purifying respirator 
may be the most convenient and practi­
cal way to provide protection to workers 
needing to enter the spray enclosure 
after the spraying process is complet­
ed. A NIOSH-approved, full-facepiece, 
air-purifying respirator equipped with a 
combination organic vapor/N95 filter car­
tridge is the minimum acceptable protec­
tion necessary after spraying is complete 
and when no exposure assessment data 
or ventilation purge data are available.
■ Use a full-facepiece to provide the neces­
sary eye and dermal exposure protection.
■ Because MDI has inadequate warning 
properties (i.e., odor threshold) and is 
a potent sensitizer, follow a changeout 
schedule to ensure that the air-purifying 
respirator cartridge is replaced before sat­
uration of the cartridge elements. Since 
MDI in this industry is principally an aero­
sol, equipping the air-purifying respirator 
with a particulate pre-filter element to 
protect the cartridge filter from prema­
ture clogging would extend the life of the 
more expensive filter/cartridge.
■ Before re-entry, allow sufficient time for 
the ventilation system to remove airborne 
MDI (see Appendix B to calculate purge 
time). NIOSH exposure assessments de­
termined that three air changes, com­
bined with gravitational settling, was suffi­
cient to reduce the MDI concentrations to 
less than 50% of the NIOSH ceiling limit 
at every sampled site (see Appendix B for 
details).
Develop a respiratory protection program
■ Develop a written, site-specific respira­
tory protection program that, at a mini­
mum, meets the requirements of the
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OSHA respiratory protection standard 
[29 CFR 1910.134] (See Appendix C).
■ Fully implement the respiratory protec­
tion program to protect spray gun users 
and any other workers who enter the 
spray enclosure.
■ When respirators are needed to protect 
the health of the worker or when respira­
tors are required by the employer, select 
a NIOSH-certified respirator based on
(1) the respiratory hazards to which the 
worker is exposed and (2) workplace and 
user factors that affect respirator perfor­
mance and reliability [29 CFR 1910.134 
(d)(1)(i) and (ii)].
■ Refer to the following publications for 
additional information about selection, 
fit-testing, use, storage, and cleaning of 
respiratory equipment:
— NIOSH Guide to Industrial Respira­
tory Protection [NIOSH 1987]
— NIOSH Respirator Selection Logic 
2004 [NIOSH 2004] www.cdc.gov/ 
niosh/docs/2005-100
— NIOSH Certified Equipment List (CEL). 
The CEL is a database of all certi­
fied respirators. It can be accessed 
at www.cdc.gov/niosh/npptl/topics/ 
respirators/CEL/default.htm]
The following links provide additional guid­






Personal P rotective Clothing
When spraying MDI-based products or dur­
ing entry immediately after spraying, wear
Figure 3. Worker wearing protective clothing and equipment.
protective clothing such as hooded coveralls, 
chemical-resistant gloves, and footwear to 
protect the skin of the face, scalp, and neck 
areas from MDI aerosol as recommended 
in the publications Quick Selection Guide to 
Chemical Protective Clothing [Forsberg and 
Mansdorf 2003] and PMDI User Guidelines 
for Protective Clothing Selection [API 2002] 
(see Figure 3).
Worker and Employer Education 
Employers
Worker education is vital to an effective occu­
pational safety and health program. To com­
ply with the OSHA hazard communication
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standard [29 CFR 1910.1200], inform
workers about the following:
■ Methods and observations that may be 
used to detect the presence or release 
of a hazardous chemical in the work area 
(such as monitoring conducted by the 
employer, continuous monitoring devices, 
visual appearance or odor of hazardous 
chemicals when being released, etc.)
■ Physical and health hazards of the chem­
icals in the work area, including the likely 
physical symptoms or effects of over­
exposure
■ Protective measures, such as engineer­
ing controls, appropriate work practices, 
emergency procedures, and personal 
protective equipment
■ The details of the hazard communica­
tion program developed by the employer, 
including an explanation of the labeling 
system, the MSDSs, and means for work­
ers to obtain and use the appropriate haz­
ard information
Workers and employers
■ Use this Alert to facilitate chemical haz­
ard training for workers spraying MDI- 
based products, including spray-on truck 
bed linings.
■ Obtain MSDSs from suppliers or manu­
facturers.
Chemical manufacturers and distributors
■ Provide customers with information about 
the health effects of your products, in­
cluding MSDSs and labels.
■ Develop safe handling procedures for the 
chemicals and equipment used in the 
spraying of MDI-base products. Ensure 
that the end users are informed of these 
procedures.
■ Provide easy-to-read information explain­
ing the health effects of your products 
and steps to keep workers safe. Include 
safe handling brochures such as the API 
brochure Truck Bed Liner: Worker Protec­
tion [API 2004b]. The API brochure is a 
good example of manufacturers working 
cooperatively to improve worker safety by 
communicating important information in 
an easy-to-read format.
Medical M onitoring
■ Conduct preplacement examinations to 
obtain baseline health status.
— Include all potentially exposed work­
ers for the early detection and pre­
vention of the acute and chronic ef­
fects of exposure to isocyanates.
— Consult an occupational medicine 
physician who (1) has sufficient train­
ing and experience to recognize the 
adverse health effects of exposure 
to isocyanates and (2) is aware of 
the control measures required to de­
crease potential worker exposures.
— Include the following in preplacement 
examinations:
1. A standardized questionnaire 
that includes detailed medical 
and work histories with em­
phasis on respiratory or aller­
gic conditions
2. A physical examination that 
centers on the respiratory tract
3. Baseline pulmonary function 
tests (including FEV1 and FVC).
■ Inform workers who report pre-existing 
asthma or severe allergies on the preplace­
ment examination that it will be difficult to 
monitor their health status and that if they
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become sensitized to MDI, their asthma 
symptoms are likely to worsen.
■ Conduct periodic examinations to up­
date medical and work histories every 
6 months during the initial 24 months of 
potential exposure and annually thereaf­
ter, with repeat pulmonary function tests 
every 1 to 2 years.
■ Increase the frequency of the periodic 
examinations if indicated by the health 
status of the worker or if there is reason 
to suspect a lapse in control of isocya­
nate exposures.
■ In case of onset or progression of asthma­
like symptoms or excessive declines in 
lung function, arrange for a thorough 
medical evaluation to determine the 
presence of asthma.
— If asthma is present, establish the re­
lationship to the work environment.
— Ensure that any person who has been 
medically evaluated and determined 
to be sensitized to isocyanates (in­
cluding MDI) stop all exposure to the 
implicated agent. Several references 
are available to guide the evaluation 
of symptoms in exposed persons 
[Nicholson et al. 2005; Friedman- 
Jiménez et al. 2000].
■ Record and store information in such a 
way as to be usable for both the ongo­
ing respiratory protection program and 
to evaluate the distribution of respiratory 
complaints, patterns of decline in respi­
ratory function, or sentinel events.
■ Although respiratory protection programs 
have a separate function from medical 
monitoring, information obtained through 
a respiratory protection program can be
incorporated and used as part of an over­
all medical surveillance program.
■ Consult published literature for infor­
mation about how successful medical 
monitoring programs are associated 
with an earlier recognition and improved 
prognosis for workers who develop occu­
pational asthma [Liss et al. 2000; Tarlo 
et al. 2002, 1997a, 1997b, 1995].
Surveillance and Disease Reporting
■ To enhance the uniformity of reporting 
work-related asthma, use the report­
ing guidelines and asthma surveillance 
case definition and case classification 
(see Appendix D). These guidelines and 
case definition, which have been updated 
since the 1996 NIOSH Alert, are recom­
mended for public health surveillance of 
work-related asthma reported by physi­
cians and other health care providers 
[NIOSH 1996; Jajosky et al. 1999]. As of 
2004, six States—California, Massachu­
setts, Michigan, New Jersey, New York, 
and Washington—are actively engaged 
in work-related asthma surveillance and 
preventive activities; one other State— 
Connecticut— has a work-related asthma 
surveillance system in place (see Appen­
dix E for State contact information for 
these States).
Decontam ination and Waste Disposal
■ If you are a manufacturer or distributor, 
establish procedures for decontamina­
tion, waste disposal, and transport for 
isocyanate-contaminated materials or 
equipment. Further information about 
waste disposal is available through local, 
State, or Federal EPA offices (www.epa. 
gov); the Alliance for the Polyurethanes 
Industry (API) (www.polyurethane.org);
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and MDI and TDI: Safety, Health and the 
Environment [Allport 2003].
FUTURE RESEARCH AND 
PRODUCTS
NIOSH is continuing research on solutions 
for the spray-on truck bed liner industry 
in collaboration with other government 
agencies, academia, and industry repre­
sentatives. This research includes the fo l­
lowing:
■ Investigation of the particle size distri­
bution of the overspray and the relative 
contributions of gravitational settling and 
ventilation in removing MDI from the at­
mosphere of the spray enclosure.
■ Design and evaluation of a negative- 
pressure ventilation system to reduce 
MDI concentrations within the spray 
enclosure and to prevent escape of MDI 
to other areas.
■ Analytical methods research for MDI and 
other isocyanates.
■ Production and dissemination of a 
NIOSH Workplace Solutions document 
detailing ventilation designs and work 
practices for the spray-on truck bed 
liner industry.
Kenneth R. Mead, M.S., PE.1; Don J. Lof- 
gren, C.I.H.3; Dave Bonauto, M.D., M.PH.3; 
Alberto Garcia, M.S.1; Roland Berry Ann1; 
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Lee Petsonk, M.D.1
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tistical support and G. Edward Burroughs, 
Ph.D., C.I.H., C.S.P,1 provided guidance 
and review.
Susan Afanuh, Anne C. Hamilton, and Van­
essa Becks provided editorial and production 
services.
Please direct comments, questions, or re­
quests for additional information to the fol­
lowing:
Dr. Mary Lynn Woebkenberg 
Director, Division of Applied Research 
and Technology 
National Institute for Occupational Safety 
and Health 
4676 Columbia Parkway 
Cincinnati, OH 45226-1998
Telephone: 513-533-8462; or call 
1-800-35-NIOSH (1-800-356-4674)
We greatly appreciate your assistance in 
protecting the lives of U.S. workers.
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APPENDIX A
This appendix includes (1) a definition of 
isocyanates and MDI terms used in the text,
(2) a list of commonly used synonyms for 
MDI monomer, (3) a table of Chemical Ab­
stract Service (CAS) numbers associated 
with MDI, their CAS name and common 
names or descriptions, and (4) a table of 
several manufacturers’ MDI-based products 
used in the truck bed liner industry and their 
associated CAS numbers.
The spray-on truck bed liner industry uses 
MDI-based products as one component of 
a two component spray-on process. Com­
ponent A typically contains a mixture of MDI 
monomer(s) and modified MDI. All have re­
active isocyanate groups present and should 
be considered possible health hazards.
ISOCYANATE DEFINITIONS AND 
CHEMICAL STRUCTURE
An isocyanate is any compound that con­
tains the -NCO functional group. A func­
tional group is any group of atoms that 
represents a potential reaction site in an 
organic compound. An isocyanate thus has 
a nitrogen (N), carbon (C), and oxygen (O) 
bonded together in such a way as to cre­
ate a reactive site within the molecule. In 
this document, the term diisocyanate re­
fers to a chemical compound that contains 
two isocyanate groups (NCO) per molecule. 
When specifically referring to the diisocya­
nate methylenebis(phenyl isocyanate), the 
term MDI monomer will be used. The MDI 
monomer is depicted in Figure 1. The term 
MDI refers to a mixture containing any com­
bination of MDI monomer, MDI prepolymer, 
or polymeric MDI. Figure 1. MDI Monomer





4,4 ’-Diphenylmethane diisocyanate 











Methylene bisphenyl isocyanate (Chemical name used in OSHA documents.) 
Sources: Lewis [1993], NIOSH [1995], Sax and Lewis [1987].
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Table 1. CAS numbers associated with MDI*
CAS number CAS pre ferred name
Description/ 
common names
101-68-8 benzene, 1,1’-methylenebis[4-isocyanato- 4 ,4 ’-MDI isomer, pure MDI
5873-54-1 benzene, 1-isocyanato-2-[(4-isocyanatophenyl) 
methyl]-
2,4 ’-MDI isomer
2536-05-2 benzene, 1,1’-methylenebis[2-isocyanato- 2,2 ’-MDI isomer
26447-40-5 benzene, 1,1’-methylenebis[isocyanato- MDI (generic), mixture of isomers
9016-87-9 isocyanic acid,
polymethylenepolyphenylene ester
PMDI, polymeric MDI (generic), 
mixture of chemical homologues 
made from the phosgenation of 
the reaction product of aniline 
and formaldehyde
25686-28-6 benzene, 1,1’-methylenebis[4-isocyanato-, 
homopolymer
Main components of polymeric 
MDI, mixture of chemical homo­
logues derived from the 4 ,4 ’- 
MDI isomer
17589-24-1 1,3-diazetidine-2,4-dione, 1,3-bis[4- 
[(4-isocyanatophenyl) methyl]phenyl]-
4 ,4 ’-MDI dimer, self-reaction 
product
31107-36-5 1,3-diazetidin-2-one, 1,3-bis[4-[(4- 
isocyanatophenyl) methyl]phenyl]-4-[[4- 
[(4-isocyanatophenyl)methyl]phenyl]imino]-
Uretonimine of 4 ,4 ’-MDI, a 
modified MDI (variant) made 
from self-reaction of 4 ,4 ’-MDI at 
high temperatures
39310-05-9 benzene, 1,1’-methylenebis[isocyanato-, 
homopolymer
Generic polymeric MDI, mixture 
of chemical homologues derived 
from the mixture of MDI isomers
S ou rce : A llp o rt e t al. [2 0 0 3 ].  
*This lis t is n o t all inc lus ive .
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Table 2. CAS numbers associated with specific MDI productsf
Company CAS number Description
The Dow Chemical 
Company
26447-40-5 5 MDI products support the TBL business.
All but one contains MDI prepolymers, which 
generally do call out the MDI prepolymer CAS 
number on the MSDS.
Bayer MaterialScience 39420-98-9 Bayer systems that are sold into the TBL indus­
try are identified as Baytec SPR 085A and Bay- 
tec SPR 092A. Component A of each of these 




The first two CAS numbers are for commercial 
Tuff Stuff A Side. The last CAS number is for 




























4 ,4 ’-Diphenylmethane Diisocyanate 
Modified MDI
S ou rce : API
T h is  lis t is n o t all inc lus ive .




This Appendix contains information about 
spray enclosure and ventilation design, in­
cluding how to determine the number of air 
changes per hour and calculate the mini­
mum required purge time.
When substitution is not feasible, engineer­
ing controls should be the primary method 
for reducing airborne isocyanates in the 
workplace. Spray enclosures should incor­
porate exhaust ventilation systems designed 
to contain, capture and remove vapors and 
particulates. It is generally advisable to 
minimize the size and volume of the spray 
area while seeking to increase the exhaust 
capacity from the spray area. General de­
sign concepts and operating considerations 
for the ventilation control of occupational 
exposures may be found in the most recent 
edition of Industrial Ventilation: A Manual 
o f Recommended Practice, published by 
the American Conference of Governmen­
tal Industrial Hygienists (ACGIH) [ACGIH 
2004b].
The design and operation of a ventilated 
spray enclosure for MDI-based spray-on 
bed liners should include the following four 
parameters with the aim of containing and 
minimizing exposure to MDI and maintaining 
exposure to MDI monomer below the NIOSH 
10-minute ceiling limit and OSHA 15-minute 
ceiling limit of 0.2 mg/m3:
1. The spray enclosure should be de­
signed as a negative pressure enclo­
sure to prevent leakage of airborne 
MDI into other work areas within the 
shop. Three different design configura­
tions have been identified to lower MDI 
concentrations within the spray enclo­
sure and prevent escape to adjacent 
work areas:
■ A spray booth similar to that used 
in the automotive paint spray in­
dustry; or
■ A spray enclosure (smallest floor 
area and room volume compati­
ble with the operation) that incor­
porates local exhaust ventilation 
hood(s) to capture and remove 
MDI near the point(s) of genera­
tion; or
■ A spray enclosure (smallest floor 
area and room volume compat­
ible with the operation) that uses 
a general ventilation system to 
dilute airborne contaminants. 
The ventilation system’s make-up 
air supply and exhaust locations 
should be strategically placed to 
generate a directed air flow that 
pushes airborne contaminant to­
ward the exhaust points to maxi­
mize ventilation efficiency and 
contaminant control.
2. If MDI were removed solely by dilution 
ventilation using an efficient (well-mixed) 
system design, the recommended three
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air changes would be sufficient to 
remove 95% of the airborne MDI af­
ter spraying has ceased. However, 
NIOSH field experience has shown 
that gravitational settling contributes 
significantly to the removal of the MDI 
aerosol. When these two removal 
mechanisms act together, the time 
required to achieve three air changes 
was more than sufficient to reduce the 
MDI concentrations to less than 50% 
of the NIOSH ceiling limit in every field 
situation evaluated by NIOSH. During 
the purge time any worker entering the 
spray enclosure should continue to use 
the necessary respiratory protection 
(see Respiratory Protection section).
Ventilation System Capabilities
■ Obtain a site-specific exposure assess­
ment that includes sampling data at de­
sired intervals following the spraying op­
eration. These data are the best way to 
determine the purge time (time required 
to reduce MDI concentrations consistent­
ly below the NIOSH REL) required for your 
ventilation system.
■ In the absence of exposure assessment 
data, determine the time required for the 
ventilation system to exhaust an air vol­
ume equal to a single air change.
■ Calculate the required purge time, allow­
ing sufficient time for at least three com­
plete air exchanges—or even longer for 
systems with poor air mixing.
■ During the purge time, use respirato­
ry protection when entering the spray
enclosure (see Respiratory Protection in 
Recommendations).
Purge Time
■ To calculate the time required to exhaust 
an air volume equal to a single room air 
change, you must know the exhaust ca­
pacity of the fan (as installed) as well as 
the dimensions of the spray area.
(L x  W x  H) 
Q
where:
T = time for one air change
(minutes)
L = length of spray enclosure (feet)
W = width of spray enclosure (feet)
H = height of spray enclosure (feet)
Q = fan capacity in cubic feet per
minute (cfm)
■ A minimum purge time of three air 
changes (3 x  T) is recommended for 
spray enclosures that incorporate very 
good ventilation efficiency (that is, mix­
ing factor close to 1.0), such as those 
discussed in item 1 above. Less efficient 
designs will need to multiply the calcu­
lated time requirement by a mixing fac­
tor between 2 and 10, depending upon 
the prevalence of dead air spots within 
the spray area [ACGIH 2004]. During the 
recommended purge time, workers en­
tering the spray enclosure should con­
tinue using respiratory protection.
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APPENDIX C
This appendix contains additional informa­
tion about full-facepiece, supplied-air respi­
rators and a respiratory protection program.
SUPPLIED-AIR RESPIRATORS
Many issues pertaining to this industry led 
to the selection of the full-facepiece, sup- 
plied-air respirator as the most appropri­
ate respirator during the spray-on process. 
These reasons include the following:
■ MDI is a potent sensitizer and a NIOSH- 
approved supplied-air respirator provides 
a higher level of protection, thus lowering 
the potential for sensitization.
■ A supplied-air respirator provides the 
high level of protection needed in a work 
environment in which concentations of 
MDI aerosol are highly variable with un­
predictable spikes to concentrations well 
above the NIOSH REL.
■ A supplied-air respirator decreases the 
possibility of momentary breakthrough in 
a work environment in which an air-puri­
fying filter cartridge would likely become 
clogged, leading to higher breathing re­
sistance and leakage around the side of 
the mask.
■ Full-facepiece, supplied-air respirators 
provide the eye and dermal protection 
necessary from the aerosolized spray-on 
product.
■ An air-purifying respirator requires fre­
quent cartridge changes due to the con­
centrations documented.
ELEMENTS OF A RESPIRATORY 
PROTECTION PROGRAM
A complete respiratory protection program
as required by 29 CFR 1910.134 (c) (1) (i)
through 1910.134 (c) (1) (ix) shall include
the following:
■ Procedures for selecting respirators for 
use in the workplace
■ Medical evaluations of employees re­
quired to use respirators
■ Fit-testing procedures for tight-fitting res­
pirators
■ Procedures for proper use of respirators 
in routine and reasonably foreseeable 
emergency situations
■ Procedures and schedules for cleaning, 
disinfecting, storing, inspecting, repair­
ing, discarding, and otherwise maintain­
ing respirators
■ Procedures to ensure adequate air qual­
ity, quantity, and flow of breathing air for 
atmosphere-supplying respirators
■ Training of employees in the respiratory 
hazards to which they are potentially 
exposed during routine and emergency 
situations
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■ Training of employees in the proper use 
of respirators, including putting on and 
removing them, any limitations on their 
use, and their maintenance
■ Procedures for regularly evaluating the 
effectiveness of the program
Appropriate management is a critical part of 
an effective respiratory protection program.
Therefore, the program should be evaluated 
regularly as required by 1910.134 (c) (1) 
and administered by a qualified program 
administrator as required by 1910.134 (c)
(3). Workers using supplied-air respirators 
must follow the manufacturer’s instructions 
on how to maintain and verify the specified 
minimum air pressure for the respirator.
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APPENDIX D
Surveillance Guidelines for State Health Departments 
Work-Related Asthma
REPORTING GUIDELINES
State health departments should encourage 
health-care professionals to report back all 
the diagnosed or suspected cases of asthma 
that are caused or exacerbated by workplace 
exposures or conditions. Reported cases 
should include asthma caused by sensitizers 
or irritants and should include cases of reac­
tive airways dysfunction syndrome.
SURVEILLANCE CASE DEFINITION
The surveillance case definition requires
1. a health care professional’s diagnosis 
consistent with asthma and
2. an association between symptoms of 
asthma and work.
Asthma is a chronic condition characterized 
by inflammation of the tracheobronchial tree 
associated with increased airways respon­
siveness to a variety of stimuli. Symptoms 
of asthma include episodic wheezing, chest 
tightness, cough, and dyspnea, or recurrent 
attacks of bronchitis with cough and sputum 
production. The primary physiological mani­
festation of airways hyperresponsiveness is 
variable or reversible airflow obstruction. It 
is commonly demonstrated by significant 
changes in the forced expiratory volume in
1 second (FEV^ or peak expiratory flow rate. 
Airflow changes can occur spontaneously, 
with treatment, with a precipitating expo­
sure, or with diagnostic maneuvers such as 
nonspecific inhalation challenge.
Patterns of association can vary and include 
the following:
■ Symptoms of asthma that develop or 
worsen after a worker starts a new job or 
after new materials are introduced on a 
job (a substantial period can elapse be­
tween initial exposure and development 
of symptoms)
■ Symptoms that develop within minutes of 
specific activities or exposures at work
■ Delayed symptoms that occur several 
hours after exposure (for example, dur­
ing the evenings of workdays)
■ Symptoms that occur less frequently or 
not at all on days away from work and on 
vacations
■ Symptoms that occur more frequently 
when the affected worker returns to work
■ Symptoms that are temporally associat­
ed with workplace exposure to an agent 
with irritant properties
Work-related changes in medication require­
ments can accompany these symptom pat­
terns.
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APPENDIX E
Contact Information for Selected States
The following States have surveillance sys­
tems for work-related asthma:
California
California Department of Health Services
Occupational Health Branch
850 Marina Bay Parkway




CAL/OSHA Consultation Service 
Department of Industrial Relations 
2424 Arden Way, Suite 485 




State of Connecticut Department of 
Public Health 
410 Capitol Avenue, Mail Stop: 11 OSP 
PO. Box 340308 
Hartford, CT 06134-0308 
860-509-7744
www.dph.state.ct.us/BRS/EOHA/HPEEOH.html
Connecticut Department of Labor 
Division of Occupational Safety and Health 
38 Wolcott Hill Road 




Massachusetts Department of 
Public Health 
Occupational Health Surveillance Program 
250 Washington Street, 6th Floor 
Boston, MA 02108 
617-624-5632
www.mass.gov/dph/bhsre/ohsp/ohsp.htm
MA Division of Occupational Safety 
On-site Consultation Program 
Department of Labor and 
Workforce Development 
1001 Watertown Street 




Michigan Department of Labor and 
Economic Growth 
Michigan Occupational Safety and Health 
Administration (MIOSHA)
Consultation, Education, and 
Training Division 
7150 Harris Drive 
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Michigan State University
Department of Medicine
Occupational and Environmental Medicine
117 West Fee Hall




New Jersey Department of Health 
and Senior Services 
Occupational Health Surveillance Program 
PO. 360, Room 701 
Trenton, NJ 08625-0360 
609-984-1863 
www.nj.gov/health/eoh/survweb
NJ Department of Health and Senior Services 
Public Employees Occupational Safety 
and Health Consultation Project 
PO. Box 360




New Jersey Department of Labor 
and Workforce Development 
Division of Public Safety and Occupational 
Safety and Health 




State of New York Department 
of Health 
Center for Environmental Health 
Bureau of Occupational Health 
Flanigan Square 
547 River Street, Room 230 




New York State Department 
of Labor 
Division of Safety and Health 
Onsite Consultation Program 
State Office Campus, Bldg. 12, RM 168 




Washington State Department of Labor 
and Industries 
Safety and Health Assessment and 
Research for Prevention (SHARP) Program 
PO. Box 44330 
Olympia, WA 98504-4330 
888-667-4277
www.lni.wa.gov/Safety/Research/default.asp
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DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Centers for Disease Control and Prevention 
National Institute for Occupational Safety and Health 
4676 Columbia Parkway 
Cincinnati, Ohio 45226-1998
1/IO SH
Delivering on the Nation's promise: 
Safety and health at work for all people 
through research and prevention
To receive NIOSH documents or more information 
about occupational safety and health topics, 
contact NIOSH at
1-800-35-N IO SH  (1 -800-356-4674)
Fax: (513) 533-8573  
E-mail: pubstaft@cdc.gov
or visit the NIOSH Web site at www.cdc.gov/niosh 
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